Investigator Racial Diversity and Clinical Trial Participation

How to cite

Alsan, Marcella; Leister, Lukas; Campbell, Romaine; Ojo, Ayotomiwa. 2023. "Investigator Racial Diversity and Clinical Trial Participation." AEA RCT Registry. AEARCTR-0011926. https://doi.org/10.1257/rct.11926-1.1

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Marcella Alsan* , Lukas Leister , Romaine Campbell , Ayotomiwa Ojo

* Primary investigator

Registry ID
AEARCTR-0011926
DOI
https://doi.org/10.1257/rct.11926-1.1
First registered
Last updated
Status
Completed
Trial dates
2021-06-04 – 2022-02-21
Countries
United States of America ()
JEL codes
I14, I18, O38, O32
Secondary IDs
ClinicalTrials.gov: NCT04938895
Registry record
http://www.socialscienceregistry.org/trials/11926

Abstract

Participation of Black patients in clinical trials remains low relative to population and disease-burden benchmarks. We investigate whether increased racial diversity of trial principal investigators could increase enrollment of Black patients. To do so, we conducted a survey experiment in which respondents were shown a photo of a current NIH investigator in which race (Black/White) was cross-randomized as was gender (male/female) to provide a relevant benchmark. Black respondents reported 10.5 percent higher interest in participating in a clinical study led by a race concordant investigator. Gender concordance had no effect. Multivariate regression analyses point to perceived trustworthiness as the most important factor in explaining the pattern of results. Our findings suggest that increasing the racial diversity of clinical trial investigators is a potentially effective method for encouraging enrollment of Black participants in medical research.

*Please see ClinicalTrials.gov NCT04938895 for more information and pre-registration.

Intervention

We plan to recruit subjects and randomly assign them to one of four treatments. In each treatment arm, the subject will view a photograph of a real NIH investigator. We experimentally vary treatment along two dimensions: whether the sender is Black or white and whether the sender is male or female.

Experimental design

We plan to recruit subjects and randomly assign them to one of four treatments. In each treatment arm, the subject will view a photograph of a real NIH investigator. We experimentally vary treatment along two dimensions: whether the sender is Black or white and whether the sender is male or female.

Our primary aim is to assess whether the subject's stated willingness to participate in a clinical trial led by the investigator. Our secondary aim is to assess whether the subject is a more objective measure of interest in signing up for information on other clinical trials. To assess mechanisms, we will ask the respondent to rate the subject's perceived trustworthiness and quality of the investigator. In addition, we will also assess the subject's perceived attractiveness and age of the investigator as well as the subject's risk aversion, altruism, time preference, and general trust.

Design details

Randomization method
Randomization was computer-generated and performed using Qualtrics’ own functionality.
Randomization unit
Individual
Clusters
412
Observations
412
Arms
80 subjects in Black Woman Investigator arm, 81 subjects in Black Man Investigator arm, 78 subjects in White Woman Investigator arm, 84 subjects in White Man Investigator arm.
Primary outcomes
Willingness to Participate in a Clinical Trial

Cited by

No citation data available for this registration yet.

Keywords